The international HTA database returned incomplete search results for NICE technology appraisals: An exploratory study and discussion of the implications
- PMID: 40476009
- PMCID: PMC11795885
- DOI: 10.1002/cesm.12034
The international HTA database returned incomplete search results for NICE technology appraisals: An exploratory study and discussion of the implications
Abstract
Introduction: The International Network of Agencies for Health Technology Assessment (INAHTA) database offers a single point of access for identifying technology appraisals, in contrast to searching multiple websites directly. The aim of this research is to compare the coverage of the INAHTA and Centre for Reviews and Dissemination (CRD) Health Technology Assessment (HTA) databases with direct searching on the National Institute for Health and Care Excellence (NICE) website to identify Technology Appraisals published by NICE.
Methods: NICE Technology Appraisals were downloaded from the NICE website (April 2022). Technology Appraisals were randomized and the first 20 Technology Appraisals constituted data for analysis. The INAHTA and CRD HTA databases were searched to determine if the 20 Technology Appraisals available on the NICE website were also available for retrieval.
Results: Coverage was incomplete. INAHTA: 15 of 20 Technology Appraisals (75%) were not identified via full title or intervention-specific searches. CRD HTA: 7 of 12 Technology Appraisals (58%) that were published before the last update of the database were not identified.
Conclusion: Findings indicate that researchers seeking to identify NICE Technology Appraisals should search the NICE website directly. How this finding impacts identification of guidance from other agencies should be evaluated.
Keywords: HTA; Health Technology Assessment; INAHTA; International Network of Agencies for Health Technology Assessment database; National Institute for Health and Care Excellence.
© 2023 The Authors. Cochrane Evidence Synthesis and Methods published by John Wiley & Sons Ltd on behalf of The Cochrane Collaboration.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092. GMS Health Technol Assess. 2011. PMID: 21468289 Free PMC article.
-
Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia.Curr Oncol. 2022 Oct 13;29(10):7624-7636. doi: 10.3390/curroncol29100602. Curr Oncol. 2022. PMID: 36290879 Free PMC article.
-
Reporting of Patient and Public Involvement in Technology Appraisal and Assessment Reports: A Rapid Scoping Review.Patient. 2025 Mar;18(2):109-114. doi: 10.1007/s40271-024-00721-7. Epub 2024 Nov 2. Patient. 2025. PMID: 39487952
-
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.Health Technol Assess. 2021 Dec;25(76):1-228. doi: 10.3310/hta25760. Health Technol Assess. 2021. PMID: 34990339
-
Is the National Institute for Health and Care Excellence (NICE) in England more 'innovation-friendly' than the Federal Joint Committee (G-BA) in Germany?Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):453-462. doi: 10.1080/14737167.2019.1559732. Epub 2018 Dec 30. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30556745
References
-
- National Institute for Health and Care Excellence (NICE). Guide to the Processes of Technology Appraisal. 2018. https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NIC... - PubMed
-
- Centre for Reviews and Dissemination (CRD). HTA Database. University of York; 2022. Accessed June 19, 2022. https://www.crd.york.ac.uk/CRDWeb/
-
- International Network of Agencies for Health Technology Assessment (INAHTA). HTA Database. 2020. Accessed June 19, 2020. https://www.inahta.org/hta-database/
-
- The National Institute for Health and Care Excellence (NICE) . [TA210] Clopidogrel and Modified‐Release Dipyridamole for the Prevention of Occlusive Vascular Events. 2010. https://www.nice.org.uk/guidance/ta210
LinkOut - more resources
Full Text Sources
Miscellaneous